Merge to acquire Interpra Medical Imaging

Article

Merge Technologies has signed a letter of intent to acquire Interpra Medical Imaging, a Toronto, Ontario-based developer of Java-based clinical workflow and information management software. Merge plans to offer Interpra’s products directly to end

Merge Technologies has signed a letter of intent to acquire Interpra Medical Imaging, a Toronto, Ontario-based developer of Java-based clinical workflow and information management software. Merge plans to offer Interpra’s products directly to end users as well as through its OEM/VAR channels. Interpra president and chief medical officer Dr. Stephen Herman will stay on as Merge’s chief medical officer.

The stock-for-stock transaction is expected to be completed by the end of August, subject to the execution of a definitive agreement, completion of due diligence, regulatory approvals, and closing conditions. Interpra shareholders would receive 420,000 shares of Merge stock, along with an equal number of put options exercisable in five years for $4.50 each. Merge’s stock closed at $1.44 per share on July 27.

In other Merge news, the Milwaukee-based company posted a revenue increase of 47% during its second quarter (end-June). Revenues were $2.8 million, compared with $1.9 million for the same period in 1998. Merge recorded a net loss of $584,000, compared with a net loss of $683,000 last year. Merge’s results were below analysts’ expectations, however.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.